Skip to content

Attention to users of Alcohol, Tobacco and other Drugs in a university hospital

Attention to users of Alcohol, Tobacco and other Drugs in a university hospital: the care network

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5krbwzd
Enrollment
39
Registered
2026-07-27
Start date
2023-02-02
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcoholism, Smoking, Substance-Related Disorders, Anxiety, Depression and Self-Control Substance-Related Disorders

Interventions

This is a quantitative, analytical, clinical, pre-experimental, and longitudinal study, with variables measured at three different time points. The intervention under study is the Motivational Nursing
of these, 39 met the inclusion criteria and attended the first Motivational Nursing Consultation. Data from 21 participants were analyzed, as they completed the five Motivational Nursing Consultations

Sponsors

Hospital Universitário Cassiano Antônio Moraes (Hucam)
Lead Sponsor
Centro de Estudos e Pesquisa sobre Álcool e outras Drogas (Cepadi)
Collaborator
Hospital Universitário Cassiano Antônio Moraes (Hucam)
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: People aged 18 or older; have self-reported episode of alcohol consumption within the last 30 days; be under medical follow-up at the Outpatient Alcoholism Program (PAA); be available to participate in five Motivational Nursing Consultations (CEM), within a 90-day interval

Exclusion criteria

Exclusion criteria: Present visible difficulty to understand and express oneself as a result of alcohol consumption or self-reported or recorded cognitive neurological sequelae in an online medical record; severe psychiatric illness such as schizophrenia or psychotic disorder; refusal to answer follow-up questionnaires; inability to attend five Motivational Nursing Consultations (CEM), within a 90-day interval. To avoid a measurement bias, participants with ongoing hospitalization, after the start of the research, did not have their data included for analysis, as the consumption pattern may have been influenced by the hospitalization event rather than by the offer of the Motivational Nursing Consultations (CEM), as they were in a secluded environment

Design outcomes

Primary

MeasureTime frame
Expected primary outcome 1: It is expected to find a reduction in the number of drinking days and heavy drinking days over a 90-day period, verified using the adapted Quick Drinking Assessment Interview (FORM-90-AQ).;Found primary outcome 1: A statistically significant reduction of 9.6 days in the drinking pattern and 9.0 days in heavy drinking over the last 30 days was observed, verified using the adapted Quick Drinking Assessment Interview (FORM-90-AQ), after the 90-day intervention period.

Secondary

MeasureTime frame
Expected secondary outcome 1: It is expected to find a reduction in anxiety, depression, and stress symptoms, evaluated by the Depression, Anxiety and Stress Scale (DASS-21); a reduction in the level of dependence, evaluated by the Short Alcohol Dependence Data (SADD); and an increase in readiness to change, evaluated by a readiness ruler, culminating in improved perceived change, evaluated by the Questionnaire of Perceived Changes (QPC) over a 90-day period.;Found secondary outcome 1: A statistically significant reduction was observed in stress (-2.6 points) and depression (-2.9 points) symptoms by the Depression, Anxiety and Stress Scale (DASS-21), along with a reduction in the dependence level score (-2.9 points) by the Short Alcohol Dependence Data (SADD), and an increase in perceived change (+2.8 points) by the Questionnaire of Perceived Changes (QPC). No statistically significant effects were observed for anxiety symptoms and readiness to change.

Countries

BR

Contacts

Public ContactLucas Subrinho

Centro de Estudos e Pesquisa sobre Álcool e outras Drogas (Cepadi)

lucas.subrinho@ebserh.gov.br+55(27)3335-7492

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Aug 10, 2026